B · Normal
[Afternoon session of the third day of the 2026 National Talks: BeiGene, Colombotel, Roche, and Daiichi Sankyo will appear] September 7th, at about 13:00 today, the third day of the 2026 National Basic Medical Insurance Drug List Negotiation and Bidding and the Commercial Insurance Innovative Drug List Price Negotiation will begin. The midday session started. Reporters observed at the scene that domestic and foreign companies such as Colombotech, BeiGene, Roche, AstraZeneca, Hengrui Pharmaceuticals, Daiichi Sankyo, Novartis, Pierre Fabre, Sanofi, Bristol-Myers Squibb, Pfizer, etc. entered the negotiation room, and about 20 companies were negotiating. (Reporters Lu Afeng and Yu Miao)
Comments